Skip to content

CROI: Growth hormone stimulant TH9507 safe and effective in HIV lipodystrophy

CROI: Alendronate effectively treats bone loss in men and women with HIV

CROI: Lower CD4 count on HIV treatment predicts higher risk of cancers, liver, kidney, cardiovascular disease

CROI: Efavirenz-based ART more effective than nevirapine-based ART as first-line therapy in Southern Africa

CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy

CROI: Urgent action needed to avert `catastrophic` drug-resistant TB epidemic

Health Canada issues warning on use of Baraclude alone in HIV/hepatitis B coinfected

Poor infection control, not poor adherence, responsible for vast majority of drug-resistant TB in Chinese study

Anti-herpes treatment reduces HIV levels; treatment or vaccine urged for HIV prevention